Susquehanna International Group’s Biotricity, Inc. Common Stock BTCY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-30,533
Closed -$63.8K 13529
2023
Q3
$63.8K Buy
+30,533
New +$73.8K ﹤0.01% 11189
2023
Q2
Sell
-9,551
Closed -$26.6K 13429
2023
Q1
$26.6K Buy
9,551
+3,337
+54% +$13.7K ﹤0.01% 11962
2022
Q4
$16.8K Sell
6,214
-116
-2% -$641 ﹤0.01% 11820
2022
Q3
$30K Buy
+6,330
New +$44.4K ﹤0.01% 12449
2022
Q1
Sell
-4,570
Closed -$79.3K 14202
2021
Q4
$109K Buy
+4,570
New +$108K ﹤0.01% 12085

Other funds holding BTCY

Susquehanna International Group's BTCY Position: Q4 2023 in Review

Susquehanna International Group sold out of Biotricity, Inc. Common Stock (BTCY) in Q4 2023, closing a stake of 30,533 shares — an estimated $63.8K sold.

Susquehanna International Group first reported a position in BTCY in Q4 2021 and held it in 5 quarters. The position peaked at $109K in Q4 2021. 21 funds tracked by Wall St. Rank hold BTCY as of Q4 2023.

  • Susquehanna International Group reported no remaining Biotricity, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • Susquehanna International Group sold 30,533 Biotricity, Inc. Common Stock shares in Q4 2023, an estimated $63.8K.
  • Susquehanna International Group first reported a position in Biotricity, Inc. Common Stock in Q4 2021 and held it in 5 quarters.
  • Susquehanna International Group's Biotricity, Inc. Common Stock position peaked at $109K in Q4 2021.
  • 21 funds tracked by Wall St. Rank held Biotricity, Inc. Common Stock as of Q4 2023.

Based on Susquehanna International Group's 13F filing for Q4 2023, filed 14 Feb 2024.